CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Electra Therapeutics Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Electra Therapeutics Inc
230 E Grand Avenue,, Suite S-100
Phone: (302) 531-0855p:302 531-0855 SOUTH SAN FRANCISCO, CA  94080  United States Ticker: ETRAETRA
Business Summary
Electra Therapeutics, Inc. is a clinical-stage biotechnology company that is developing novel antibody therapies directed at the family of signal regulatory proteins (SIRP) to treat severe immune-mediated and oncologic diseases. Its lead product candidate, ELA026, is a first-in-class monoclonal antibody targeting SIRP on myeloid and T cells. In addition to ELA026, The Company is advancing a second SIRP-targeted program (ELA822) and other internally generated pre-clinical programs aimed at inflammation, immunology, and oncology indications. Its services include target discovery, antibody engineering, and clinical development of these therapies, all grounded in its proprietary SIRP-based mechanism of action.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202612/31/2025YesYes---

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board Nancy E.Stagliano 59 3/1/2019 3/1/2019
President, Chief Executive Officer, Director QuehuongDong 44 10/1/2023 10/1/2023
Chief Financial Officer ChrisClark 48 8/1/2026 12/1/2025
7 additional Officers and Directors records available in full report.

Business Names
Business Name
ELECTRA THERAPEUTICS INC.
ETRA

General Information
Number of Employees: 46 (As of 6/30/2026)
Stock Exchange: NASD
Federal Tax Id: 832193635
Fax Number: (302) 531-3150
Email Address: info@electra-therapeutics.com


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, October 15, 2026